Loading…

S204: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONTLINE CHEMOTHERAPY: THE PHASE 2, OPEN‐LABEL, KEYNOTE‐667 STUDY

Saved in:
Bibliographic Details
Published in:HemaSphere 2022-06, Vol.6, p.105-106
Main Authors: Vinti, L., Daw, S., Sabado Alvarez, C., Fagioli, F., Beishuizen, A., Michel, G., Moleti, M. L., Cepelova, M., Thorwarth, A., Rigaud, C., Plaza Lopez de Sabando, D., Landman Parker, J., Zhu, Y., Pillai, P., Nahar, A., Mauz‐Koerholz, C.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000843708.43092.96